Editas Medicine EDIT reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Editas Medicine beat estimated earnings by 5.81%, reporting an EPS of $-0.81 versus an estimate of $-0.86.
Revenue was down $6.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 2.46% increase in the share price the next day.
Here's a look at Editas Medicine's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Editas Medicine visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.